コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 dividuals with emphysema secondary to severe alpha1 antitrypsin deficiency.
2 led trial of A1PI treatment in patients with alpha1 antitrypsin deficiency.
3 which underlies misfolding diseases such as alpha1-antitrypsin deficiency.
4 ding Gaucher disease, cystic fibrosis and ZZ alpha1-antitrypsin deficiency.
5 that underlies emphysema in individuals with alpha1-antitrypsin deficiency.
6 stemic inflammatory diseases associated with alpha1-antitrypsin deficiency.
7 apy for treatment of liver diseases, such as alpha1-antitrypsin deficiency.
8 tions in CF, primary ciliary dyskinesia, and alpha1-antitrypsin deficiency.
9 clinically and cost-effective therapies for alpha1-antitrypsin deficiency.
10 re, early-onset COPD probands without severe alpha1-antitrypsin deficiency.
11 a 34-year-old man with cirrhosis related to alpha1-antitrypsin deficiency.
17 ng of genetic and nongenetic modifiers in ZZ alpha1-antitrypsin deficiency and other disorders of pro
18 the end-stage liver disease associated with alpha1-antitrypsin deficiency and underscore the contrib
19 netic disorders, such as cystic fibrosis and alpha1-antitrypsin deficiency, and for other diseases, i
20 with either alcohol-related liver disease or alpha1-antitrypsin deficiency, and only one of the healt
21 he most frequent mutation that causes severe alpha1-antitrypsin deficiency arises in the SERPINA 1 ge
25 Less common causes include hemochromatosis, alpha1-antitrypsin deficiency, autoimmune hepatitis, and
27 blished pulmonary mechanics in patients with alpha1-antitrypsin deficiency, chronic obstructive pulmo
28 ess of augmentation therapy (Aug) for severe alpha1-antitrypsin deficiency, comparing strategies of:
29 sensitive measure of disease progression in alpha1 antitrypsin deficiency emphysema than spirometry
30 ents with CF, primary ciliary dyskinesia, or alpha1-antitrypsin deficiency exhibited 3-fold higher mu
31 abolic conditions studied in further detail (alpha1-antitrypsin deficiency, familial hypercholesterol
33 inhibitor (A1PI) augmentation treatment for alpha1 antitrypsin deficiency has not been substantiated
34 mphysema progression in patients with severe alpha1 antitrypsin deficiency in a randomised controlled
40 tients with alcohol-related liver disease or alpha1-antitrypsin-deficiency liver disease, and only on
42 verity and distribution in 119 subjects with alpha1-antitrypsin deficiency (PiZ phenotype) and groupe
43 y centres in 13 countries if they had severe alpha1 antitrypsin deficiency (serum concentration <11 m
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。